Spectrum Antimicrobials
Spectrum Antimicrobials is dedicated to the prevention and treatment of infections through innovative anti-infective chemistries. Their mission is to improve patient lives by developing first-in-class products that address one of the most difficult issues in global healthcare, including antibiotic-resistant bacteria, viruses, fungi, mold, and spores. They focus on creating products that prevent infections, reduce topical pain and itch, and accelerate wound healing, with applications across surgical sites, invasive surgeries, burn and wound care, dermatology, ophthalmology, and medical devices. Their proprietary platforms are highly effective against a broad spectrum of pathogens without encouraging resistance. Spectrum Antimicrobials aims to reshape the standard of care and improve healthcare outcomes worldwide.
Industries
Nr. of Employees
small (1-50)
Spectrum Antimicrobials
Petaluma, California, United States
Products
Nasal wash (R&D candidate)
An all-natural sinus/nasal wash formulation intended to relieve congestion, dryness and sinus symptoms; formulated with natural preservatives for daily use.
Nebulized antiviral pulmonary solution (R&D candidate)
A pulmonary antiviral/antibacterial formulation intended for nebulizer delivery to moisturize airways and assist mucus breakup, under partner-assisted clinical evaluation for safety and efficacy.
Spectricept
An advanced HOCl-based skin and wound cleanser that received FDA clearance for U.S. prescription and OTC markets, as well as a second 510(k) clearance without use restrictions.
Spectricept Hand Sanitizer
An advanced hand sanitizer approved for sale within the UK NHS hospital system.
SPC-02
A weaponized protein technology drug candidate offering 4,000X greater efficacy than conventional HOCl, maintaining activity in high-protein environments, and penetrating bacterial biofilms.
SPX-001
Broad-spectrum antiviral and antibacterial drug candidate optimized for the treatment of pulmonary infections, designed for inhalation delivery.
Nasal wash (R&D candidate)
An all-natural sinus/nasal wash formulation intended to relieve congestion, dryness and sinus symptoms; formulated with natural preservatives for daily use.
Nebulized antiviral pulmonary solution (R&D candidate)
A pulmonary antiviral/antibacterial formulation intended for nebulizer delivery to moisturize airways and assist mucus breakup, under partner-assisted clinical evaluation for safety and efficacy.
Spectricept
An advanced HOCl-based skin and wound cleanser that received FDA clearance for U.S. prescription and OTC markets, as well as a second 510(k) clearance without use restrictions.
Spectricept Hand Sanitizer
An advanced hand sanitizer approved for sale within the UK NHS hospital system.
SPC-02
A weaponized protein technology drug candidate offering 4,000X greater efficacy than conventional HOCl, maintaining activity in high-protein environments, and penetrating bacterial biofilms.
SPX-001
Broad-spectrum antiviral and antibacterial drug candidate optimized for the treatment of pulmonary infections, designed for inhalation delivery.
Services
Manufacture, label and deliver finished anti-infective products to distribution partners.
Assistance preparing regulatory submissions and navigating approval pathways for anti-infective products.
Support for partner-led human clinical trials for respiratory/inhalation candidates, including endpoint definition and safety/efficacy evaluation.
Manufacture, label and deliver finished anti-infective products to distribution partners.
Assistance preparing regulatory submissions and navigating approval pathways for anti-infective products.
Support for partner-led human clinical trials for respiratory/inhalation candidates, including endpoint definition and safety/efficacy evaluation.
Expertise Areas
- Anti-infective formulation development
- Preclinical GLP testing and regulatory compliance
- Clinical trial support for respiratory and topical therapies
- Wound care and surgical-site infection prevention
Key Technologies
- Antimicrobial and antiviral chemistries
- Topical and wound-care formulations
- Nebulizer-compatible inhalation formulations
- GLP-compliant preclinical testing
News & Updates
Impact of Obstructive Sleep Apnea on Healthcare Utilization
Studies on how diagnosing and treating obstructive sleep apnea can impact healthcare resource utilization.
Sleep Disorders and PTSD
Research on the association between sleep disorders, PTSD, and the impact of CPAP therapy.
Correlation Between Positive Airway Pressure and Medication Adherence
A study exploring the relationship between positive airway pressure therapy and medication adherence.
Impact of Group Education on CPAP Adherence
Research on how group education influences adherence to CPAP therapy in sleep apnea patients.
Sleep and Performance in Military Personnel
Studies on how sleep affects soldier performance and the management of sleep disorders in military populations.
Innovations in Sleep Medicine and Disasters
Discussions on new guidelines, disaster response, and innovations in sleep medicine.
Impact of Obstructive Sleep Apnea on Healthcare Utilization
Studies on how diagnosing and treating obstructive sleep apnea can impact healthcare resource utilization.
Sleep Disorders and PTSD
Research on the association between sleep disorders, PTSD, and the impact of CPAP therapy.
Correlation Between Positive Airway Pressure and Medication Adherence
A study exploring the relationship between positive airway pressure therapy and medication adherence.
Impact of Group Education on CPAP Adherence
Research on how group education influences adherence to CPAP therapy in sleep apnea patients.
Sleep and Performance in Military Personnel
Studies on how sleep affects soldier performance and the management of sleep disorders in military populations.
Innovations in Sleep Medicine and Disasters
Discussions on new guidelines, disaster response, and innovations in sleep medicine.